This study is designed to evaluate the safety and tolerability of LEM-S401 administered as subcutaneous injection in healthy adult subjects.~Overall, 18 subjects will be studied in 3 groups. Each subject will receive LEM-S401 or placebo subcutaneously.
The primary objective of the study is to assess the safety and tolerability of single dose of LEM-S401 in healthy adult subjects.